Impact of COVID-19 on Adult Immunization Coverage Rates and Update from CDC on Influenza Communications for 2020-21
July 30, 2020 | 9:00-11:00 am, CST
Although the data showing the dramatic impact of COVID-19 in reducing routine pediatric immunization coverage rates are clear, less information has been available on adult immunization. At this virtual meeting, a panel of 6 vaccine manufacturers presented their data on the impact of COVID-19 on adult immunization coverage rates in the United States and internationally. The presenters also included information on potential directions they plan to take in the fall to address the steep declines in adult immunization coverage rates that have been observed. In addition to this panel, Becton-Dickinson provided information on their ongoing work to ensure a stable supply chain of syringes and needles this fall, and CDC presented on their communications plans for the upcoming influenza season.
Please check below to view a recording of the entire panel discussion or to access individual presentations shared during the meeting.
Impact of COVID-19 on Adult Immunization Coverage Rates and Update from CDC on Influenza Communications for 2020-21(to be posted soon)
- Opening Welcome
Ram Koppaka, MD, PhD
Associate Director for Adult Immunization, Immunization Services Division
Centers for Disease Control and Prevention (CDC)
David Kim
Director, Division of Vaccines
Office of the Assistant Secretary for Health (OASH)
L.J Tan
Chief Strategy Officer
Immunization Action Coalition (IAC)
- CDC’s 2020-2021 Flu Vaccine Communications
Erin Burns
Lead, Influenza Division Communications Team
Centers for Disease Control and Prevention (CDC)
- On the Front Line ™ Against Influenza
Tara Charvat
Senior Director, US Marketing
Seqirus
- COVID-19 Impact on Immunizations
Julian Ritchey
VP, Head of Public Affairs and Patient Advocacy, US Vaccines
Sanofi Pasteur
- Changes in Adult Pneumococcal Immunization During COVID-19 Pandemic
Alejandro Cane
Medical and Scientific Affairs Lead, North America Region
Pfizer
- Impact of COVID-19 Pandemic on Adult Vaccination
(slides not posted at presenter’s request)
Myriam Exume
Executive Director, US Marketing Adult Vaccines
Merck
- Raising Adult Immunization Rates in the COVID-19 Environment
Luis Morales
Senior Director, Adult Vaccines
GSK
- HCP Interactions in a CV-19 World
Alan Green
US Commercial Lead
AstraZeneca
- Influenza Vaccination Season 2020-2021 Injection Device Planning
Daniel Smith
Business Director, US Region Injection Systems
Program Leader, US Vaccination Campaign
BD Medication Delivery Solutions